Asian Science Citation Index - Articles written by J Cortes

Articles by J Cortes (3)

Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-up

H Kantarjian, J Cortes, D. W Kim, P Dorlhiac Llacer, R Pasquini, J DiPersio, M. C Muller, J. P Radich, H. J Khoury, N Khoroshko, M. B Bradley Garelik, C Zhu and M. S. Tallman

Blood 113 ( 25 ): 6322 - 6329 , 2009

Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia

D. A Thomas, S O'Brien, J. L Jorgensen, J Cortes, S Faderl, G Garcia Manero, S Verstovsek, C Koller, S Pierce, Y Huh, W Wierda, M. J Keating and H. M. Kantarjian

Blood 113 ( 25 ): 6330 - 6337 , 2009

Proteasome Enzymatic Activities in Plasma as Risk Stratification of Patients with Acute Myeloid Leukemia and Advanced-Stage Myelodysplastic Syndrome

W Ma, H Kantarjian, B Bekele, A. C Donahue, X Zhang, Z. J Zhang, S O`Brien, E Estey, Z Estrov, J Cortes, M Keating, F Giles and M. Albitar

Clinical Cancer Research 15 ( 11 ): 3820 - 3826 , 2009